![1]()
News
FDA approves Xofluza for treatment of influenza
October 24, 2018
The FDA has approved Xofluza for acute uncomplicated influenza in people aged 12 years or older who have been symptomatic for 48 hours or less.
![1]()
News
Stroke risk in elderly following AMI extends to 12 weeks
October 24, 2018
ATLANTA – The prolonged period of heightened risk was evident in patients with both STEMI and NSTEMI.
![1]()
News
Drug overdose deaths down since late 2017
October 23, 2018
Longer-term trend, however, shows an increase of 2.7% during the 12 months ending in March 2018, compared with March 2017.
![1]()
News
Reducing alarm fatigue
October 22, 2018
A centralized monitoring system might help reduce unimportant alarms with no increase in cardiopulmonary arrest events.
![1]()
News
Readmission to non-index hospital following acute stroke linked to worse outcomes
October 22, 2018
ATLANTA – Study adds to the stroke literature on nationwide estimates of 30-day readmissions.
![1]()
News
Blood test may obviate need for head CTs in brain trauma evaluation
October 20, 2018
SAN DIEGO – A biomarker blood test to evaluate patients for suspected TBI was associated with a high negative predictive value in a large trial.
![1]()
News
DAPT’s benefit after stroke or TIA clusters in first 21 days
October 19, 2018
MONTREAL – The superiority of clopidogrel plus aspirin over aspirin alone was apparent only during the first 21 days of treatment.
![1]()
News
Smartphone device beat Holter for post-stroke AF detection
October 18, 2018
MONTREAL – In 294 post-stroke patients, atrial fibrillation screening with a smartphone-based device detected more cases than Holter monitoring.
![1]()
Opinion
How much more proof do you need?
October 16, 2018
Why are there still proponents for lengthy IV therapy when oral therapy works just as well?
![1]()
News
Protocol violations, missed transfusions among blood delivery errors
October 16, 2018
BOSTON – Nearly one-third of transfusion errors reported by pediatric units were linked to a “this kid is special” hubris among providers, investigators said.
